MedTrace Logo

The Halland Osteoarthritis Cohort

NCT04928170 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 312

Last updated 2024-10-01

No results posted yet for this study

Summary

Osteoarthritis is the most common musculoskeletal disease and is characterized by cartilage destruction, osteophyte formation, subchondral bone sclerosis and cysts. Modern treatment strategies, as well as preventive measures, include early detection and knowledge of the early course of the disease. This includes how stress patterns, physical activity, impaired function and metabolic changes and other comorbidities affect development and possible associations with osteoarthritis.

The overall objective was to study the early development of osteoarthritis of the knee and its association with hand- and general osteoarthritis, metabolic diseases, biomarkers, long-term pain, physical function and stress patterns

Conditions

  • Osteoarthritis, Knee
  • Osteoarthritis Hand
  • Osteoarthritis Generalized

Sponsors & Collaborators

  • The Swedish Rheumatism Ass

    collaborator OTHER

  • FoU Center Spenshult

    lead OTHER

Principal Investigators

  • Maria LE Andersson, ass.prof. · FoU Spenshult

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2019-10-01
Completion
2024-12-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04928170 on ClinicalTrials.gov